Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-4 of 4

Sort by

Sort Order Select

Journal Articles

HIV-1 Protease Inhibitor, Ritonavir: A Potent Inhibitor of CYP3A4, Enhanced the Anticancer Effects of Docetaxel in Androgen-Independent Prostate Cancer Cells In vitro and In vivo

Takayuki Ikezoe, Yasuko Hisatake, Tamotsu Takeuchi, Yuji Ohtsuki, Yang Yang, Jonathan W. Said, Hirokuni Taguchi, H. Phillip Koeffler

Cancer Res (2004) 64 (20): 7426–7431.

https://doi.org/10.1158/0008-5472.CAN-03-2677

Published: 15 October 2004

View articletitled, HIV-1 Protease Inhibitor, Ritonavir: A Potent Inhibitor of CYP3A4, Enhanced the Anticancer Effects of Docetaxel in Androgen-Independent Prostate Cancer Cells In vitro and In vivo

Journal Articles

HIV-1 protease inhibitor, ritonavir: A potent inhibitor of CYP 3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

Takayuki Ikezoe, Yasuko Hisatake, Jonathan W. Said, Hirokuni Taguchi, H. Phillip Koeffler

Cancer Res (2004) 64 (7_Supplement): 140.

Published: 01 April 2004

View articletitled, HIV-1 protease inhibitor, ritonavir: A potent inhibitor of CYP 3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

Journal Articles

24-Oxo Metabolites of Vitamin D₃ Analogues: Disassociation of Their Prominent Antileukemic Effects from Their Lack of Calcium Modulation

Masaaki Shiohara, Milan Uskokovic, Junichi Hisatake, Yasuko Hisatake, Kenichi Koike, Atsushi Komiyama, H. Phillip Koeffler

Cancer Res (2001) 61 (8): 3361–3368.

Published: 15 April 2001

View articletitled, 24-Oxo Metabolites of Vitamin D3 Analogues: Disassociation of Their Prominent Antileukemic Effects from Their Lack of Calcium Modulation

Journal Articles

5,6-trans-16-ene-Vitamin D₃: A New Class of Potent Inhibitors of Proliferation of Prostate, Breast, and Myeloid Leukemic Cells

Jun-ichi Hisatake, Tetsuya Kubota, Yasuko Hisatake, Milan Uskokovic, Shigeru Tomoyasu, H. Phillip Koeffler

Cancer Res (1999) 59 (16): 4023–4029.

Published: 15 August 1999

View articletitled, 5,6-trans-16-ene-Vitamin D3: A New Class of Potent Inhibitors of Proliferation of Prostate, Breast, and Myeloid Leukemic Cells

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

HIV-1 Protease Inhibitor, Ritonavir: A Potent Inhibitor of CYP3A4, Enhanced the Anticancer Effects of Docetaxel in Androgen-Independent Prostate Cancer Cells In vitro and In vivo

HIV-1 protease inhibitor, ritonavir: A potent inhibitor of CYP 3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

24-Oxo Metabolites of Vitamin D₃ Analogues: Disassociation of Their Prominent Antileukemic Effects from Their Lack of Calcium Modulation

5,6-trans-16-ene-Vitamin D₃: A New Class of Potent Inhibitors of Proliferation of Prostate, Breast, and Myeloid Leukemic Cells

Email alerts

AACR Journals

Update search

HIV-1 Protease Inhibitor, Ritonavir: A Potent Inhibitor of CYP3A4, Enhanced the Anticancer Effects of Docetaxel in Androgen-Independent Prostate Cancer Cells In vitro and In vivo

HIV-1 protease inhibitor, ritonavir: A potent inhibitor of CYP 3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

24-Oxo Metabolites of Vitamin D3 Analogues: Disassociation of Their Prominent Antileukemic Effects from Their Lack of Calcium Modulation

5,6-trans-16-ene-Vitamin D3: A New Class of Potent Inhibitors of Proliferation of Prostate, Breast, and Myeloid Leukemic Cells

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

24-Oxo Metabolites of Vitamin D₃ Analogues: Disassociation of Their Prominent Antileukemic Effects from Their Lack of Calcium Modulation

5,6-trans-16-ene-Vitamin D₃: A New Class of Potent Inhibitors of Proliferation of Prostate, Breast, and Myeloid Leukemic Cells